# European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial

> **NCT01087723** · PHASE3 · COMPLETED · sponsor: **The Medicines Company** · enrollment: 2198 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Bivalirudin
- **DRUG:** Heparin

## Key facts

- **NCT ID:** NCT01087723
- **Lead sponsor:** The Medicines Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2013-08
- **Final completion:** 2014-08
- **Target enrollment:** 2198 (ACTUAL)
- **Last updated:** 2016-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01087723

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01087723, "European Ambulance Acute Coronary Syndrome (ACS) Angiography Trial". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01087723. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*